Drug Targets Faulty Process That Drives Cystic Fibrosis
WEDNESDAY, Nov. 17 (HealthDay News) -- A new drug focused on the underlying cause of cystic fibrosis is showing promise in Phase II clinical trials, new research shows.
Read more on HealthDay via Yahoo! News
Orignal From: Drug Targets Faulty Process That Drives Cystic Fibrosis
Post a Comment